Jean-Louis Arcand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jean-Louis Arcand has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Edith Patouillard
World Health Organization, Geneva, Switzerland
3 shared publications - Daniele Rinaldo
University of Exeter
2 shared publications - Jeremy Addison Lauer
Strathclyde Business School, University of Strathclyde, Glasgow, UK
2 shared publications Matthias Rieger
2 shared publications- Natascha Wagner
Institute for Management Research Radboud University Nijmegen the Netherlands
2 shared publications - Patrick Guillaumont
FERDI, Clermont Ferrand, France
2 shared publications
Latest Publications
- Open Access
- 14 December 2023
- Published by Springer Nature in Research Square
Guns, Germs, and Slaves: an Alternative View of the Colonial Origins of Comparative Development
This paper shows that early colonial interactions between Europeans and indigenous populations, specifically the deaths of the latter, have long-term effects on economic development. We propose an alternative view on the historical origins of comparative development, arguing for links between pre-colonial conditions, colonial-era practices, and growth centuries later. We explore the decades of first contact between Europeans and the indigenous population for both violence against that population and the type of political-economic regime established. These violence and regime consequences affected the strength or weakness of property-protecting institutions, with the latter in turn influencing per capita income today. JEL: O43, O47, N40
- 14 December 2023
- Published by Springer Nature in Research Square
Open AccessGuns, Germs, and Slaves: an Alternative View of the Colonial Origins of Comparative Development
This paper shows that early colonial interactions between Europeans and indigenous populations, specifically the deaths of the latter, have long-term effects on economic development. We propose an alternative view on the historical origins of comparative development, arguing for links between pre-colonial conditions, colonial-era practices, and growth centuries later. We explore the decades of first contact between Europeans and the indigenous population for both violence against that population and the type of political-economic regime established. These violence and regime consequences affected the strength or weakness of property-protecting institutions, with the latter in turn influencing per capita income today. JEL: O43, O47, N40
- 9 December 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 340, 116486
COVID-19's death transfer to Sub-Saharan Africa
- 9 December 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 340, 116486
COVID-19's death transfer to Sub-Saharan Africa
- Open Access
- 4 October 2023
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 12 (1)
The Macroeconomic Impact of Increasing Investments in Malaria Control in 26 High Malaria Burden Countries: An Application of the Updated EPIC Model
Background: Malaria remains a major public health problem. While globally malaria mortality affects predominantly young children, clinical malaria affects all age groups throughout life. Malaria not only threatens health but also child education and adult productivity while burdening government budgets and economic development. Increased investments in malaria control can contribute to reduce this burden but have an opportunity cost for the economy. Quantifying the net economic value of investing in malaria can encourage political and financial commitment. Methods: We adapted an existing macroeconomic model to simulate the effects of reducing malaria on the gross domestic product (GDP) of 26 high burden countries while accounting for the opportunity costs of increased investments in malaria. We compared two scenarios differing in their level of malaria investment and associated burden reduction: sustaining malaria control at 2015 intervention coverage levels, time at which coverage levels reached their historic peak and scaling-up coverage to reach the 2030 global burden reduction targets. We incorporated the effects that reduced malaria in children and young adolescents may have on the productivity of working adults and on the future size of the labour force augmented by educational returns, skills, and experience. We calibrated the model using estimates from linked epidemiologic and costing models on these same scenarios and from published country-specific macroeconomic data. Results: Scaling-up malaria control could produce a dividend of US$ 152 billion in the modelled countries, equivalent to 0.17% of total GDP projected over the study period across the 26 countries. Assuming a larger share of malaria investments is paid out from domestic savings, the dividend would be smaller but still significant, ranging between 0.10% and 0.14% of total projected GDP. Annual GDP gains were estimated to increase over time. Lower income and higher burden countries would experience higher gains. Conclusion: Intensified malaria control can produce a multiplied return despite the opportunity cost of greater investments.
- 4 October 2023
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 12 (1)
Open AccessThe Macroeconomic Impact of Increasing Investments in Malaria Control in 26 High Malaria Burden Countries: An Application of the Updated EPIC Model
Background: Malaria remains a major public health problem. While globally malaria mortality affects predominantly young children, clinical malaria affects all age groups throughout life. Malaria not only threatens health but also child education and adult productivity while burdening government budgets and economic development. Increased investments in malaria control can contribute to reduce this burden but have an opportunity cost for the economy. Quantifying the net economic value of investing in malaria can encourage political and financial commitment. Methods: We adapted an existing macroeconomic model to simulate the effects of reducing malaria on the gross domestic product (GDP) of 26 high burden countries while accounting for the opportunity costs of increased investments in malaria. We compared two scenarios differing in their level of malaria investment and associated burden reduction: sustaining malaria control at 2015 intervention coverage levels, time at which coverage levels reached their historic peak and scaling-up coverage to reach the 2030 global burden reduction targets. We incorporated the effects that reduced malaria in children and young adolescents may have on the productivity of working adults and on the future size of the labour force augmented by educational returns, skills, and experience. We calibrated the model using estimates from linked epidemiologic and costing models on these same scenarios and from published country-specific macroeconomic data. Results: Scaling-up malaria control could produce a dividend of US$ 152 billion in the modelled countries, equivalent to 0.17% of total GDP projected over the study period across the 26 countries. Assuming a larger share of malaria investments is paid out from domestic savings, the dividend would be smaller but still significant, ranging between 0.10% and 0.14% of total projected GDP. Annual GDP gains were estimated to increase over time. Lower income and higher burden countries would experience higher gains. Conclusion: Intensified malaria control can produce a multiplied return despite the opportunity cost of greater investments.
- Open Access
- 23 May 2023
- Published by Elsevier in Journal of Mathematical Economics
- Vol. 107
Can one hear the shape of a target zone?
- 23 May 2023
- Published by Elsevier in Journal of Mathematical Economics
- Vol. 107
Open AccessCan one hear the shape of a target zone?
- Open Access
- 23 April 2023
- Published by SAGE Publications in Political Research Quarterly
- Vol. 76 (4) , 1646-1660
Segregation and “Out-of-Placeness”: The Direct Effect of Neighborhood Racial Composition on Police Stops
Differential police conduct may be attributed both to residential racial segregation and more general discriminatory attitudes and policies. We draw upon ethnographic and other studies of everyday policing to propose that police, in the context of racially segregated neighborhoods, intensively surveil individuals who are “out of place” in terms of their race and the local geographical context in which they are found. We then use statistical evidence from the New York City Police Department to compare stops in different neighborhoods. We find that the NYPD indeed carries out “stops” that differentially target African Americans and Hispanics present in predominantly white precincts, with the degree of surveillance increasing as precincts become more white, and as stops become more generic and less about specific, identifiable crimes.
- 23 April 2023
- Published by SAGE Publications in Political Research Quarterly
- Vol. 76 (4) , 1646-1660
Open AccessSegregation and “Out-of-Placeness”: The Direct Effect of Neighborhood Racial Composition on Police Stops
Differential police conduct may be attributed both to residential racial segregation and more general discriminatory attitudes and policies. We draw upon ethnographic and other studies of everyday policing to propose that police, in the context of racially segregated neighborhoods, intensively surveil individuals who are “out of place” in terms of their race and the local geographical context in which they are found. We then use statistical evidence from the New York City Police Department to compare stops in different neighborhoods. We find that the NYPD indeed carries out “stops” that differentially target African Americans and Hispanics present in predominantly white precincts, with the degree of surveillance increasing as precincts become more white, and as stops become more generic and less about specific, identifiable crimes.
- Open Access
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries
Most individuals who develop tuberculosis (TB) are working-age adults living in low- and middle-income countries (LMICs). The resulting disability and death impacts economic productivity and burdens health systems. New TB vaccine candidates may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on GDP growth in 105 LMICs, using a macroeconomic model to simulate country-level GDP trends between 2020 and 2080, in 2020 USD. We compared scenarios for introduction of infant and adolescent/adult vaccine candidates to a no-new-vaccine counterfactual. Compared to the no-new-vaccine counterfactual, both vaccination scenarios produced greater cumulative GDP in the modelled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8–3.0) trillion for the adolescent/adult vaccine, and $0.2 ($0.1–0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, and concentrated in countries with higher current TB incidence.
Open AccessThe potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries
Most individuals who develop tuberculosis (TB) are working-age adults living in low- and middle-income countries (LMICs). The resulting disability and death impacts economic productivity and burdens health systems. New TB vaccine candidates may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on GDP growth in 105 LMICs, using a macroeconomic model to simulate country-level GDP trends between 2020 and 2080, in 2020 USD. We compared scenarios for introduction of infant and adolescent/adult vaccine candidates to a no-new-vaccine counterfactual. Compared to the no-new-vaccine counterfactual, both vaccination scenarios produced greater cumulative GDP in the modelled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8–3.0) trillion for the adolescent/adult vaccine, and $0.2 ($0.1–0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, and concentrated in countries with higher current TB incidence.
- Open Access
- 13 December 2021
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 10 (1) , 1-12
The economic impact of schistosomiasis
Background: The economic impact of schistosomiasis and the underlying tradeoffs between water resources development and public health concerns have yet to be quantified. Schistosomiasis exerts large health, social and financial burdens on infected individuals and households. While irrigation schemes are one of the most important policy responses designed to reduce poverty, particularly in sub-Saharan Africa, they facilitate the propagation of schistosomiasis and other diseases. Methods: We estimate the economic impact of schistosomiasis in Burkina Faso via its effect on agricultural production. We create an original dataset that combines detailed household and agricultural surveys with high-resolution geo-statistical disease maps. We develop new methods that use the densities of the intermediate host snails of schistosomiasis as instrumental variables together with panel, spatial and machine learning techniques. Results: We estimate that the elimination of schistosomiasis in Burkina Faso would increase average crop yields by around 7%, rising to 32% for high infection clusters. Keeping schistosomiasis unchecked, in turn, would correspond to a loss of gross domestic product of approximately 0.8%. We identify the disease burden as a shock to the agricultural productivity of farmers. The poorest households engaged in subsistence agriculture bear a far heavier disease burden than their wealthier counterparts, experiencing an average yield loss due to schistosomiasis of between 32 and 45%. We show that the returns to water resources development are substantially reduced once its health effects are taken into account: villages in proximity of large-scale dams suffer an average yield loss of around 20%, and this burden decreases as distance between dams and villages increases. Conclusions: This study provides a rigorous estimation of how schistosomiasis affects agricultural production and how it is both a driver and a consequence of poverty. It further quantifies the tradeoff between the economics of water infrastructures and their impact on public health. Although we focus on Burkina Faso, our approach can be applied to any country in which schistosomiasis is endemic. Graphical
- 13 December 2021
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 10 (1) , 1-12
Open AccessThe economic impact of schistosomiasis
Background: The economic impact of schistosomiasis and the underlying tradeoffs between water resources development and public health concerns have yet to be quantified. Schistosomiasis exerts large health, social and financial burdens on infected individuals and households. While irrigation schemes are one of the most important policy responses designed to reduce poverty, particularly in sub-Saharan Africa, they facilitate the propagation of schistosomiasis and other diseases. Methods: We estimate the economic impact of schistosomiasis in Burkina Faso via its effect on agricultural production. We create an original dataset that combines detailed household and agricultural surveys with high-resolution geo-statistical disease maps. We develop new methods that use the densities of the intermediate host snails of schistosomiasis as instrumental variables together with panel, spatial and machine learning techniques. Results: We estimate that the elimination of schistosomiasis in Burkina Faso would increase average crop yields by around 7%, rising to 32% for high infection clusters. Keeping schistosomiasis unchecked, in turn, would correspond to a loss of gross domestic product of approximately 0.8%. We identify the disease burden as a shock to the agricultural productivity of farmers. The poorest households engaged in subsistence agriculture bear a far heavier disease burden than their wealthier counterparts, experiencing an average yield loss due to schistosomiasis of between 32 and 45%. We show that the returns to water resources development are substantially reduced once its health effects are taken into account: villages in proximity of large-scale dams suffer an average yield loss of around 20%, and this burden decreases as distance between dams and villages increases. Conclusions: This study provides a rigorous estimation of how schistosomiasis affects agricultural production and how it is both a driver and a consequence of poverty. It further quantifies the tradeoff between the economics of water infrastructures and their impact on public health. Although we focus on Burkina Faso, our approach can be applied to any country in which schistosomiasis is endemic. Graphical
- Open Access
- 12 December 2019
- Published by Elsevier in SSRN Electronic Journal
Economic Impacts of Investing in Universal Health Coverage for Low- and Lower-Middle Income Countries
We estimate the economic impacts associated with investing in Universal Health Coverage (UHC) of Childhood diseases (Malaria, Diarrhea, Pneumonia), Noncommunicable diseases, Tuberculosis, and HIV/AIDS in ten low- and lower-middle income countries that account for 67% of deaths worldwide, for the 2019-2023 period. We model the development-accounting mechanisms of improved health status and economic performance for these countries using a human capital augmented Solow model which incorporates cost effects on physical capital and demographic impacts on labor supply. The underlying dynamics of improvements in health and their effects on economic growth are quite heterogeneous across countries. On average, achieving UHC increases GDP by 0.54% and per capita GDP by 0.14% over a five year period. However, the gains in large countries that are well along the demographic and epidemiological transitions (India, China, Indonesia, Brazil) are smaller (less than 1% of GDP) than those in countries with less advanced transitions (Nigeria, Pakistan, Bangladesh; 2-4% of GDP). Sub-Saharan African countries (D.R. Congo, Angola, Ethiopia) show wide variability in gains (with a mean gain of 1-6% of GDP). Overall, our results are consistent with those presented in the WHO investment case.
- 12 December 2019
- Published by Elsevier in SSRN Electronic Journal
Open AccessEconomic Impacts of Investing in Universal Health Coverage for Low- and Lower-Middle Income Countries
We estimate the economic impacts associated with investing in Universal Health Coverage (UHC) of Childhood diseases (Malaria, Diarrhea, Pneumonia), Noncommunicable diseases, Tuberculosis, and HIV/AIDS in ten low- and lower-middle income countries that account for 67% of deaths worldwide, for the 2019-2023 period. We model the development-accounting mechanisms of improved health status and economic performance for these countries using a human capital augmented Solow model which incorporates cost effects on physical capital and demographic impacts on labor supply. The underlying dynamics of improvements in health and their effects on economic growth are quite heterogeneous across countries. On average, achieving UHC increases GDP by 0.54% and per capita GDP by 0.14% over a five year period. However, the gains in large countries that are well along the demographic and epidemiological transitions (India, China, Indonesia, Brazil) are smaller (less than 1% of GDP) than those in countries with less advanced transitions (Nigeria, Pakistan, Bangladesh; 2-4% of GDP). Sub-Saharan African countries (D.R. Congo, Angola, Ethiopia) show wide variability in gains (with a mean gain of 1-6% of GDP). Overall, our results are consistent with those presented in the WHO investment case.
- Open Access
- 4 December 2019
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (6) , 1405-1415
The Economic Burden of Malaria: Revisiting the Evidence
A portion of the economics literature has long debated about the relative importance of historical, institutional, geographical, and health determinants of economic growth. In 2001, Gallup and Sachs quantified the association between malaria and the level and growth of per capita income over the period 1965–1995 in a cross-country regression framework. We took a contemporary look at Gallup and Sachs’ seminal work in the context of significant progress in malaria control achieved globally since 2000. Focusing on the period 2000–2017, we used the latest data available on malaria case incidence and other determinants of economic growth, as well as macro-econometric methods that are now the professional norm. In our preferred specification using a fixed-effects model, a 10% decrease in malaria incidence was associated with an increase in income per capita of nearly 0.3% on average and a 0.11 percentage point faster per capita growth per annum. Greater average income gains were expected among higher burden countries and those with lower income. Growth of industries with the same level of labor intensity was found to be significantly slower in countries with higher malaria incidence. To analyze the causal impact of malaria on economic outcomes, we used malaria treatment failure and pyrethroid-only insecticide resistance as exogeneous instruments in two-stage least squares estimations. Despite several methodological challenges, as expected in these types of analyses, our findings confirm the intrinsic link between malaria and economic growth and underscore the importance of malaria control in the agenda for sustainable development.
- 4 December 2019
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (6) , 1405-1415
Open AccessThe Economic Burden of Malaria: Revisiting the Evidence
A portion of the economics literature has long debated about the relative importance of historical, institutional, geographical, and health determinants of economic growth. In 2001, Gallup and Sachs quantified the association between malaria and the level and growth of per capita income over the period 1965–1995 in a cross-country regression framework. We took a contemporary look at Gallup and Sachs’ seminal work in the context of significant progress in malaria control achieved globally since 2000. Focusing on the period 2000–2017, we used the latest data available on malaria case incidence and other determinants of economic growth, as well as macro-econometric methods that are now the professional norm. In our preferred specification using a fixed-effects model, a 10% decrease in malaria incidence was associated with an increase in income per capita of nearly 0.3% on average and a 0.11 percentage point faster per capita growth per annum. Greater average income gains were expected among higher burden countries and those with lower income. Growth of industries with the same level of labor intensity was found to be significantly slower in countries with higher malaria incidence. To analyze the causal impact of malaria on economic outcomes, we used malaria treatment failure and pyrethroid-only insecticide resistance as exogeneous instruments in two-stage least squares estimations. Despite several methodological challenges, as expected in these types of analyses, our findings confirm the intrinsic link between malaria and economic growth and underscore the importance of malaria control in the agenda for sustainable development.
- 1 April 2018
- Published by Elsevier in Economics Letters
- Vol. 165, 35-38
Credit markets with imperfect information: Risk-aversion versus pessimism
- 1 April 2018
- Published by Elsevier in Economics Letters
- Vol. 165, 35-38
Credit markets with imperfect information: Risk-aversion versus pessimism